Malignant melanoma: Clinical variants and prognostic indicators

Clinical and Experimental Dermatology

Volumn 25, Issue 6, 2000, Pages 471-475

  MacKie, R M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER REGRESSION; CANCER RESEARCH; CLINICAL FEATURE; CONGENITAL NEVUS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN ULCER;

HUMANS; MELANOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 0033774176     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2000.00692.x     Document Type: Review

References (21)

1. The histogenesis and biologic behaviour of primary human malignant melanomas of the skin
2. Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma
3. Classification of cutaneous malignant melanoma
4. Cutaneous malignant melanoma in Scotland. Incidence survival and mortality 1979-94
5. Malignant melanoma of the vulva in a nationwide 25-year study of 219 Swedish females - Clinical observations and histopathologic features
6. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females - Predictors of survival
7. Genetic and environmental influences in the development of multiple primary melanomas
8. CDKN2A Germline mutations in UK patients with familial melanoma and multiple primary melanomas
9. Age as a prognostic factor in the malignant melanoma population
10. Histologic features of tumors and the female superiority in survival from malignant melanoma
11. Survival superiority of females with melanoma
12. Lentigo maligna melanoma has no better prognosis than other types of melanoma
13. Comparison between lentigo maligna melanoma and other hostogenetic types of malignant melanoma of the head and neck
14. Primary cutaneous melanoma
15. Pathologic prognostic factors for cutaneous malignant melanoma. The Western Canada Melanoma Study
16. Model predicting survival in stage 1 melanoma based on tumor progression
17. The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: No evidence for steps in risk
18. Prognostic factors in thin cutaneous malignant melanoma
19. The regressing thin malignant melanoma
20. Regression in malignant melanoma
21. Prognositc index for malignant melanoma